Integral Health Asset Management’s Exact Sciences EXAS Stock Holding History

Integral Health Asset Management’s Portfolio EXAS Stock Details EXAS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-200,000	Closed	-$10.9M	–	91
2025 Q3	$10.9M	Buy	200,000 +100,000	+100%	+$5M	0.74%	47
2025 Q2	$5.31M	Buy	+100,000	New	+$5.08M	0.49%	52
2025 Q1	–	Sell	-150,000	Closed	-$8.43M	–	91
2024 Q4	$8.43M	Buy	150,000 +70,000	+88%	+$4.36M	0.72%	47
2024 Q3	$5.45M	Buy	+80,000	New	+$4.51M	0.61%	44
2023 Q3	–	Sell	-88,000	Closed	-$8.26M	–	76
2023 Q2	$8.26M	Sell	88,000 -74,000	-46%	-$5.77M	1.02%	41
2023 Q1	$11M	Sell	162,000 -113,000	-41%	-$7.26M	2.21%	14
2022 Q4	$13.6M	Buy	275,000 +125,000	+83%	+$5.11M	2.86%	13
2022 Q3	$4.87M	Buy	+150,000	New	+$6.18M	0.95%	42
2020 Q3	–	Sell	-55,000	Closed	-$4.78M	–	80
2020 Q2	$4.78M	Sell	55,000 -25,000	-31%	-$2M	1.43%	30
2020 Q1	$4.64M	Buy	+80,000	New	+$6.49M	2.04%	19

Other funds holding EXAS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

DKCM

Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Integral Health Asset Management's EXAS Position: Q4 2025 in Review

Integral Health Asset Management sold out of Exact Sciences (EXAS) in Q4 2025, closing a stake of 200,000 shares — an estimated $10.9M sold.

Integral Health Asset Management first reported a position in EXAS in Q1 2020 and held it in 10 quarters. The position peaked at $13.6M in Q4 2022. 711 funds tracked by Wall St. Rank hold EXAS as of Q4 2025.

Integral Health Asset Management reported no remaining Exact Sciences position as of Q4 2025 after selling out during the quarter.
Integral Health Asset Management sold 200,000 Exact Sciences shares in Q4 2025, an estimated $10.9M.
Integral Health Asset Management first reported a position in Exact Sciences in Q1 2020 and held it in 10 quarters.
Integral Health Asset Management's Exact Sciences position peaked at $13.6M in Q4 2022.
711 funds tracked by Wall St. Rank held Exact Sciences as of Q4 2025.

Based on Integral Health Asset Management's 13F filing for Q4 2025, filed 17 Feb 2026.